China’s longevity market is emerging as a powerful new growth frontier as the country enters a rapidly aging demographic era.

ATLANTA (AP) — CDC researchers are being forced to skip a pivotal conference on infectious disease this week due to the ...

The company will hold off on making a regulatory decision until it sees results from another trial testing the drug with ...

In a Phase III trial, sacituzumab tirumotecan outperformed chemo in previously treated EGFR-mutant NSCLC patients, results presented at the ESMO Congress show.

CT Sen. Saud Anwar Anwar said that Republicans are furious over a joke, but silent when our democracy, our health care and our planet are under attack.